Gaudium IVF and Women Health
GAUDIUMIVF •NSE

Gaudium IVF and Women Health

₹109.286.03 (5.84%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
103.51
Today’s high
110.39
52 week low
69.18
52 week high
163.18
Open price
105.89
Previous close
103.25
Live volume
3,20,982
Lower circuit
92.93
Upper circuit
113.57

Fundamentals

Market Cap
₹748Cr
ROE
16.06%
P/E Ratio(TTM)
32.30
EPS(TTM)
3.18
P/B Ratio
4.91
Dividend Yield
0.00%
Industry P/E
64.07
Book Value
20.92
Debt to Equity
0.16
Face Value
5

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹20.50Cr
-32.85%
₹1.78Cr
-78.71%
010203040
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+15%
3Y CAGR+33%
Profit growthValue
1Y (TTM)-42%
3Y CAGR+22%

About

Gaudium IVF and Women Health is a leading provider of Assisted Reproductive Technology (ART) and In-Vitro Fertilization (IVF) treatments in India. Established with a patient-centric approach, the company operates using a "Hub and Spoke" model to maximize its reach. It provides services across IVF, ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), egg/sperm donation, Comprehensive care for PCOD/PCOS, endometriosis, and high-risk pregnancy management.;
CEO/MD
Manika Khanna
Founded in
2015
NSE symbol
GAUDIUMIVF

Shareholding pattern

Jan '25
Sep '25
Feb '26
Mar '26
Jun '26
Shareholder details
Livesquawk •
Gaudium IVF reports Q1 revenue ₹194M, a 9% YoY increase from ₹178M. Solid top-line growth highlights improved performance in women health services.
Livesquawk •
Gaudium IVF reported Q1 net profit of 18M, down from 31M YoY.
2026
13
Aug
Quarterly Result
Release date
28
May
Annual Result
Release date
18
Mar
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks